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ttp://dx.doi.org/10.1016/j.ajpath.2014.10.018Single-nucleotide polymorphisms (SNPs) are the most common source of genetic variation within a
species; however, few investigations demonstrate how naturally occurring SNPs may increase strain
virulence. We recently used group A Streptococcus as a model pathogen to study bacteria strain
genotypeepatient disease phenotype relationships. Whole-genome sequencing of approximately 800
serotype M59 group A Streptococcus strains, recovered during an outbreak of severe invasive infections
across North America, identiﬁed a disproportionate number of SNPs in the gene encoding multiple gene
regulator of group A Streptococcus (mga). Herein, we report results of studies designed to test the
hypothesis that the most commonly occurring SNP, encoding a replacement of arginine for histidine at
codon 201 of Mga (H201R), signiﬁcantly increases virulence. Whole transcriptome analysis revealed
that the H201R replacement signiﬁcantly increased expression of mga and 54 other genes, including
many proven virulence factors. Compared to the wild-type strain, a H201R isogenic mutant strain
caused signiﬁcantly larger skin lesions in mice. Serial quantitative bacterial culture and noninvasive
magnetic resonance imaging also demonstrated that the isogenic H201R strain was signiﬁcantly more
virulent in a nonhuman primate model of joint infection. These ﬁndings show that the H201R
replacement in Mga increases the virulence of M59 group A Streptococcus and provide new insight to
how a naturally occurring SNP in bacteria contributes to human disease phenotypes. (Am J Pathol
2015, 185: 462e471; http://dx.doi.org/10.1016/j.ajpath.2014.10.018)Supported by the Fondren Foundation, Department of Pathology and
Genomic Medicine, Houston Methodist Hospital, in part by School of
Medicine and Health Sciences, Monterrey Institute of Technology grant
421460/263885 (M.S.), and in part by NIH, National Institute of Allergy
and Infectious Diseases, grant R21 AI103708 (M.K.).
Disclosures: None declared.Investigating the genetic basis for altered virulence pheno-
types of bacteria is crucial to our ability to understand human
infectious diseases. These molecular pathogenesis data are
needed to generate new clinical tools, such as diagnostics and
vaccines,1e3 and they may guide public health maneuvers
during outbreaks.4,5 Within this context, single-nucleotide
polymorphisms (SNPs) are the most common source of
genomic variation within a particular species or serotype of
bacteria.6e8 However, little data exist bearing on the effect of
naturally occurring SNPs on host-pathogen interactions and
increased strain virulence.9e12 Most investigations of strain
genotypeedisease phenotype relationships have focused onstigative Pathology.
.large regions of genetic variation, such as pathogenicity
islands, recombination events, and mobile genetic elements
(ie, plasmids), that introduce new gene content or multiple
polymorphisms to a strain.13e16 In comparison, the effect of
SNPs on strain virulence has been less intensely studied, with
Single Amino Acid Replacementmost investigations relying on randommutagenesis or animal
passage experiments to discover mutations that alter strain
phenotypes in vitro. Herein, we demonstrate that a naturally
occurring SNP in a key regulatory gene in an important
human pathogen signiﬁcantly increases the expression of
multiple virulence factors, and as a result, signiﬁcantly
increases strain virulence.
Group A Streptococcus (GAS; Streptococcus pyogenes),
a human-speciﬁc pathogen, is a major cause of morbidity and
mortality worldwide.17 GAS infections range in severity from
mild pharyngitis (strep throat) to life-threatening necrotizing
fasciitis (ﬂesh-eating disease), toxic shock syndrome, and
synovitis.18 GAS strains are taxonomically categorized by
serologic- or sequence-based typing of the highly variable
emm gene that encodes the M-protein virulence factor.19,20
To date, >200 M-types have been described.21 Although
some GAS serotypes, such as M1 and M3, are globally
disseminated,16 M59 strains are an uncommon cause of
human disease, representing <1% of GAS recovered from
large population-based studies of pharyngitis or invasive
infections.20,21 However, a hypervirulent serotype M59 GAS
clone recently emerged, and its progeny rapidly spread across
Canada and some parts of the United States to cause several
hundred severe invasive infections.22e25 To investigate the
population genetic structure of strains comprising the epidemic
and understand the host-pathogen interactions underlying
strain virulence, our laboratory sequenced the genome of
approximately 800 serotype M59 GAS strains.22e24 An un-
expected discovery was that the most highly polymorphic
gene was the multiple gene regulator of group A Streptococcus
(mga), a key transcriptional regulator that inﬂuences approxi-
mately 10% to 20% of the GAS transcriptome, depending on
the strain or serotype studied.26e28 More important, every SNP
in mga encoded a missense (amino acid changing) or nonsense
(premature protein termination) codon, suggesting selection
for altered Mga sequences. Furthermore, one particular SNP
encoding an arginine to histidine replacement in amino acid
201 of Mga (H201R) arose independently at least ﬁve times
and was identiﬁed in 34 strains overall.22 These genomic data
led us to hypothesize that the Mga H201R amino acid
replacement signiﬁcantly alters the virulence phenotype of
M59 GAS. We used genome-wide transcript studies, a mouse
model of skin and soft tissue infection, and a newly developed
nonhuman primate model of joint infection to compare Mga
wild-type and H201R strains. Results demonstrated that the
Mga H201R amino acid replacement signiﬁcantly increases
M59 GAS virulence.
Materials and Methods
Bacterial Strains and Growth Conditions
GAS strains were grown routinely on trypticase soy agar
containing 5% sheep blood or in Todd-Hewitt broth
containing 0.2% yeast extract (THY; Becton Dickinson
and Company, Franklin Lakes, NJ) at 37C with 5% CO2.The American Journal of Pathology - ajp.amjpathol.orgWhen appropriate, chloramphenicol was added to a ﬁnal
concentration of 8 mg/mL.
Genome-Wide Transcript Analysis
Serotype M59 GAS strains MGAS15252 (reference) and
MGAS18055 (naturally occurring Mga H201R sequence)
were recovered from patients in Canada with invasive
infections.23,25 Strain MGAS15252 was selected as the
reference because its genome has been sequenced to closure,
it expresses mga and Mga-regulated genes at levels similar to
other M59 GAS strains (Kachroo P), and it has been used in
numerous mouse and nonhuman primate virulence
studies.23,24 Genome-wide transcript analysis was performed
as previously described.16 Brieﬂy, triplicate cultures were
grown in THY overnight, diluted 1:50 in fresh THY media,
and harvested at late-logarithmic (OD600 Z 1) phase of
growth. RNA was stabilized (RNAprotect Bacteria Reagent;
Qiagen, Valencia, CA), cells were homogenized using bal-
listic disintegration (Lysing Matrix B and FastPrep96 Auto-
mated Homogenizer; MP Biomedicals, Santa Ana, CA), and
nucleic acids were extracted using standard methods
(RNeasy96; Qiagen). RNA quality (model 2100 Bioanalyzer;
Agilent Technologies, Santa Clara, CA) and quantity (Qubit
2.0 ﬂuorometer; Life Technologies, Carlsbad, CA) were
assessed. RNA sequencing libraries were prepared according
to manufacturer’s instructions (ScriptSeq version 2; Epi-
Centre Biotechnologies, Madison, WI), and sequenced using
a MiSeq Instrument (MiSeq reagent kit; Illumina Inc., San
Diego, CA). RNA transcripts were quantiﬁed as previously
described (CLC Bio, Cambridge, MA)29 using reference
strain MGAS15252 (http://www.ncbi.nlm.nih.gov/nuccore;
Accession number CP003116). Differences >1.7-fold and
P < 0.05, using Baggerly’s test and Bonferroni’s correction
for multiple comparisons, were considered statistically
signiﬁcant (Supplemental Table S1).
Construction of Isogenic Mutants
Isogenic mutant strains were generated using MGAS15249
because its genome has been sequenced, it is genomically
representative of the epidemic serotype M59 GAS clone, and
it has the most common allele (wild-type sequence) for all
major regulatory genes.23 An isogenic mutant strain lacking
the gene encoding mga was generated by in-frame insertional
inactivation with a spectinomycin-resistance cassette, as
previously described (Supplemental Figure S1).10 The mga-
deleted strain was then complemented in trans using the
pDC123 low-copy plasmid30 containing either no insert
(designated Dmga) or the coding sequence of the full-length
mga gene with its native promoter (designated wild type). To
generate an isogenic mutant strain carrying the Mga H201R
sequence (designated H201R), the plasmid containing the
wild-type allele was used as a template for site-directed
mutagenesis, according to the manufacturer’s instructions
(QuikChange II; Stratagene, Life Technologies). The463
Table 1 Probes and Primers Used for This Research
Primer Sequence Application
delMga A 50-ATAGCGAGTGTTGCCATGTTAG-30 Upstream fragment of mga for isogenic deletion
delMga B 50-GTTATAGTTATTATAACATGTATTATGCAT-
TAACTTCATGTCCTTATC-30
Upstream fragment of mga for isogenic deletion
delMga C 50-CTATTTAAATAACAGATTAAAAAAATTATAAAC-
ATCATCATAGGATTTCAGACGT-30
Downstream fragment of mga for isogenic deletion
delMga D 50-AATTTCCTCAGTCTTAGAGGCATCT-30 Downstream fragment of mga for isogenic deletion
delMga E 50-CATTTTCAAGAGCTAATGTTGGT-30 Sequencing and PCR confirmation of deletion mga
delMga F 50-TATACTTGTCGCTAGATTCTCT-30 Sequencing and PCR confirmation of deletion mga
delMga G 50-AGCTGCCTGCCTGTTGACCAATC-30 Sequencing and PCR confirmation of deletion mga
delMga H 50-ATCTAGCTTAGCTTGCAGATCAGTC-30 Sequencing and PCR confirmation of deletion mga
Mga-spc forward 50-GATAAGGACATGAAGTTAATGCATAATACATGTT-
ATAATAACTATAAC-30
Amplification of spec cassette
Mga-spc reverse 50-ACGTCTGAAATCCTATGATGATGTTTATAAT-
TTTTTTAATCTGTTATTTAAATAG-30
Amplification of spec cassette
pDC-Mga top 50-GGAAGATCTTAGAGTAATAGGTCAAATAATC-30 Pmga-mga cloning into pDC
pDC-Mga bottom 50-GGGAATCCATATGCTATGATGATGTTGCTTGC-30 Pmga-mga cloning into pDC
pDC-Mga Top2 50-ATGGTTCATACGGACTTG-30 Sequencing of mga
pDC-Mga Top3 50-TGCTATTAGTATCGTGACAAG-30 Sequencing of mga
pDC-Mga Bottom2 50-GATCAATCAGCTCACTT-30 Sequencing of mga
H201R top 50-GTAGATGTCAAAGTTCGTTTTACACTATTTCAG-30 Site-directed mutagenesis to introduce H201R
H201R bottom 50-CATCTACAGTTTCAAGCAAAATGTGATAAAGTC-30 Site-directed mutagenesis to introduce H201R
mga qRT forward 50-TCAATCAAGACCCGACATCA-30 RT-qPCR analysis of mga
mga qRT reverse 50-GGTCACGGCAACTTCGTATT-30 RT-qPCR analysis of mga
mga Probe 50-GCTCAATCTCAGCATCACCA-30 RT-qPCR analysis of mga
tufA qRT forward 50-CAACTCGTCACTATGCGCACAT-30 RT-qPCR analysis of tufA
tufA qRT reverse 50-GAGCGGCACCAGTGATCAT-30 RT-qPCR analysis of tufA
tuf A probe 50-CTCCAGGACACGCGGACTACGTTAAAAA-30 RT-qPCR analysis of tufA
qPCR, real-time quantitative PCR.
Sanson et alsequence of mga in all isogenic strains was veriﬁed by
Sanger dideoxynucleotide sequencing (Big Dye Terminator
and ABI 3730 DNA Analyzer; Life Technologies). No
differences in growth were observed among the isogenic
strains (Supplemental Figure S2A). A real-time PCR assay
using total genomic DNA extracted from the isogenic
strains conﬁrmed that no differences in mga gene copy
number were introduced by the in trans complementation
strategy (Supplemental Figure S2B). The sequence of all
oligonucleotides used in this research is listed in Table 1.GASeHuman Epithelial Cell Adherence Assay
Epithelial cell adherence of the isogenic M59 GAS strains
(Dmga, wild-type, and H201R) was measured as previously
described.31 Brieﬂy, the human primary keratinocyte cell line
HaCaT (Life Technologies, Grand Island, NY) was cultured in
Dulbecco’s modiﬁed Eagle’s medium (Life Technologies)
supplemented with 2 mmol/L glutamine and 10% calf serum.
HaCaT cells were resuspended at a concentration of 1  106/
mL, and 900 mL was seeded into each well of a 12-well tissue
culture plate and incubated for 24 hours at 37C with 5% CO2.
GAS strains were prepared by growing each strain to
OD600 Z 0.5 (early logarithmic phase of growth) and
resuspended in an equal volume of phosphate-buffered sa-
line, and 100 mLwas added to eachwell containing the lawn of464HaCaT cells. After incubating for 2 minutes, the supernatant
was removed and the wells were washed ﬁve times to remove
nonadherent GAS. Then, 1 mL of phosphate-buffered saline
containing 1% saponin was added to each well, and the plate
was incubated for 30 minutes at 37C to lyse the HaCaT cells.
GAS strains (adherent to the HaCaT cells) recovered from
each well were enumerated by serial dilution and plating.
Mean GAS recovered from eight biological replicates of each
strain was compared using the Mann-Whitney test (Prism
version 6; GraphPad Software, La Jolla, CA), with P < 0.05
considered to be statistically signiﬁcant.Virulence in a Mouse Model of Skin and Soft Tissue
Infection
Virulence of the isogenic M59 GAS strains (Dmga, wild-type,
and H201R) was tested using a mouse model of skin and soft
tissue infection, as previously described.23 Brieﬂy, 4- to 5-
week-old, 18- to 20-g, immunocompetent SKH1-hrBR hair-
less female mice (Charles River BRF, Houston, TX) were
inoculated in the s.c. tissue overlying the neck with 1  108
colony-forming units (CFUs; n Z 12 mice per strain). Le-
sions were measured daily using a digital caliper for 10 days,
and then on days 12 and 14 after inoculation. Mean abscess
area caused by each strain was compared using two-way
analysis of variance (Prism version 6), with P < 0.05ajp.amjpathol.org - The American Journal of Pathology
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Figure 1 Genome-wide transcript analysis of
serotype emm59 group A Streptococcus (GAS)
strains MGAS15252 (reference) and MGAS18055
(Mga H201R amino acid replacement). A: Growth
curve of strains MGAS15252 and MGAS18055.
Arrowheads indicate the 4 time points that were
tested for gene transcript studies. B: mga
expression is highest at late-logarithmic phase
(OD600Z 1.0). C: Principal component analysis is
shown for genome-wide transcript proﬁles of
strains grown to late-logarithmic phase. D: The
expression of mga and seven Mga-regulated genes
was signiﬁcantly increased in strain MGAS18055
(H201R) compared to strain MGAS15252. Mean X-
fold change in transcripts and genomic co-
ordinates are shown for each gene. *P < 0.05
compared to MGAS15252 (Baggerly’s test after
applying Bonferroni’s correction for multiple
comparisons).
Single Amino Acid Replacementconsidered to be statistically signiﬁcant. For histopathological
evaluation, skin lesions were excised en bloc and processed
using standard methods. Slides were examined independently
by two pathologists (M.S., R.J.O.) blinded to the strain treat-
ment groups, as previously described.23 Representative micro-
graphs were obtained using a BX5 microscope ﬁtted with a
DB70 digital camera (Olympus, Tokyo, Japan). The study
protocol was approved by the Houston Methodist Research
Institute (Houston, TX) Animal Care and Use Committee.
Virulence in a Nonhuman Primate Model of Joint Infection
Virulence of the isogenic M59 GAS strains (wild-type and
H201R) was also assessed using a new nonhuman primate joint
infection model. Cynomolgus macaques (Macaca fasicularis;
Charles River BRF) were inoculated in the intra-articular space
with 1 108 CFUs of thewild-type strain in the right elbow and
the isogenic H201R strain in the left elbow (nZ 3). By using
this strategy, each animal serves as its own control. The animals
were observed continuously for 7 days. On days 1, 2, 4, and 7
(one animal was examined on day 8 rather than day 7 to
accommodate vivarium scheduling) after inoculation, each
animal was sedated, a thorough physical examination was
conducted, blood and synovial ﬂuid were collected, and
radiological examination was performed using magnetic reso-
nance (MR) imaging. For quantitative culture, synovial ﬂuid
aspirated from each elbow was serially diluted, inoculated in
duplicate on trypticase soy agar, and grown as described above.
CFUs recovered per volume (mL) synovial ﬂuid were calcu-
lated, with P < 0.05 considered statistically signiﬁcant using
repeated-measures analysis of variance (XLSTAT; Addinsoft,
New York, NY). Blood cultures performed on each sampling
day conﬁrmed that the animals were not bacteremic. For
radiological examination, each arm was immobilized using
a soft cast, placed in a human wrist coil, and imaged using a
3.0-T MR imaging instrument (Ingenia; Philips Healthcare,The American Journal of Pathology - ajp.amjpathol.orgAmsterdam, the Netherlands). To compare virulence of the
isogenic wild-type (right elbow) and H201R (left elbow)
strains, the volume fraction of inﬂamed tissue of each limb at
each time point was calculated from a series of ﬁve coronal
images centered on the elbow joint. The T2maps were scaled to
make optimal use of the available dynamic range, normalized
and pseudocolored. The scaling factor was extracted from the
image headers. A lower threshold (threshold 1) of 20 was
established to capture all pixels across the entire limb. An upper
threshold (threshold 2) of 104 was established to capture all
inﬂammation above the baseline condition. Then, the volume
fraction of inﬂamed tissue was calculated as the sum total of
pixels greater than threshold 2/the sum total of pixels greater
than threshold 1. This formula yielded a volume fraction of
inﬂamed tissue<0.05 for all joints at the baseline MR imaging
studies acquired before GAS inoculation. A disease model for
each strain was then calculated using nonlinear least squares
regression (R Foundation for Statistical Computing, Vienna,
Austria). All parameters in the disease progression model were
signiﬁcantly different from 0 (P < 0.001), indicating that this
model effectively captures the progress of inﬂammation. The
study protocol was approved by the Houston Methodist
Research Institute Animal Care and Use Committee.
Results
The Mga H201R Amino Acid Replacement Signiﬁcantly
Increases Expression of mga and Mga-Regulated Genes
One possible mechanism tomarkedly alter strain virulence with
a single amino acid replacement is to target a major transcrip-
tional regulator and, thus, alter the expression of all genes under
its control.32 In other GAS serotype strains, Mga has been
implicated in the regulation of 10% to 20% of the tran-
scriptome.26e28 To begin testing the hypothesis that the Mga
H201R amino acid replacement signiﬁcantly alters the M59465
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Figure 2 The Mga H201R amino acid replacement signiﬁcantly increases strain virulence in vitro and in a mouse model of skin and soft tissue infection. A: The
isogenic Mga-deﬁcient (Dmga), wild-type, and H201R strains were incubated with human epithelial keratinocytes (HaCaT cells), and adhesion was calculated by
quantitative culture. B: The H201R amino acid replacement signiﬁcantly increases lesion size in a mouse model of skin and soft tissue infection. C: Microscopic ex-
aminationof skin lesions collected at day7 after inoculation. The abscesses causedby strainswild-type andDmgahave conﬁnedborders (inward-facingarrowheads). In
comparison, the abscess caused by strain H201R destroys more tissue and extends beyond the lateral and deep margins of the microscopic ﬁeld (outward-facing
arrowheads).Hematoxylin and eosin stainingwas used. **P< 0.01, ***P< 0.001 versus wild-type using theMann-Whitney test (A); ***P< 0.001 versus wild-type
using two-way analysis of variance (B). Original magniﬁcation, 4 (C).
Sanson et alGAS virulence phenotype, genome-wide transcript studies
were performed using a reference andMga H201R strain. GAS
strains were grown to late-logarithmic phase of growth, the
point in the GAS growth curve when mga is maximally
expressed (Figure 1, A and B). Analysis of RNA sequence data
revealed a highly similar genome-wide expression proﬁle that is
compatible with the clonal background of epidemic M59 GAS
(Figure 1C). Compared to the reference strain, 55 transcripts
demonstrated signiﬁcantly altered expression in the H201R
strain, including 48 genes with increased expression and 7
genes with decreased expression (Supplemental Table S1).
Transcripts with signiﬁcantly increased expression by the
H201R strain include mga, which is known to autoregulate its
expression, and seven proven virulence factors that are
also regulated by Mga in other GAS serotype strains
(Figure 1D).26e28 These gene expression data are consistent
with the idea that theMga H201R amino acid replacement may
increase M59 GAS virulence by increasing the expression of
mga and Mga-regulated virulence factors.
The Mga H201R Amino Acid Replacement Signiﬁcantly
Increases GAS Adherence to Human Epithelial Cells
Adhesion to human tissues is a key virulence activity under-
lying pathogen transmission, colonization, and invasion. Our
genome-wide transcript studies identiﬁed several genes with
signiﬁcantly increased expression by the Mga H201R strain,
including emm, mrp, and enn, which have been implicated in
GAS adhesion to host cells.33e35 To test the hypothesis that466the Mga H201R amino acid replacement alters GAS adhesion
to human tissues, GASeepithelial cell adhesion assays were
performed using isogenic Mga-deﬁcient (Dmga), wild-type,
and H201R strains. Consistent with our hypothesis, signiﬁ-
cantly more of the isogenic Mga H201R GAS organisms
adhered to the human cells in vitro (Figure 2A). Results also
demonstrated that deletion of Mga signiﬁcantly decreases
GAS adhesion compared to either comparator strain
(Figure 2A). Taken together, these data are consistent with the
hypothesis that the Mga H201R amino acid replacement
results in increased adhesion to human tissues and, thus, may
increase the virulence of M59 GAS.
The Mga H201R Amino Acid Replacement Signiﬁcantly
Increases GAS Virulence in a Mouse Model of Invasive
Skin and Soft Tissue Infection
Animal infection models are important for testing hypotheses
that bear on genetic alterations and strain virulence. To test the
hypothesis that the Mga H201R amino acid replacement
increases M59 GAS virulence, the isogenic Mga-deﬁcient
(Dmga), wild-type, and H201R strains were compared using a
mouse model of invasive skin and soft tissue infection. Results
demonstrated that all strains caused necrotic lesions centered at
the inoculation site (Figure 2, B and C). Consistent with our
hypothesis, the isogenic Mga H201R strain caused lesions that
were signiﬁcantly larger than either comparator strain
(Figure 2B). We next hypothesized that the increased viru-
lence of the Mga H201R strain would manifest as signiﬁcantlyajp.amjpathol.org - The American Journal of Pathology
Figure 3 The Mga H201R amino acid replace-
ment signiﬁcantly increases strain virulence in a
nonhuman primate model of joint infection. Cyn-
omolgus macaques were inoculated in the right
and left elbow with the isogenic wild-type and
H201R strains, respectively, and observed for 7
days. AeD: Magnetic resonance imaging was used
for noninvasive serial measurement of inﬂamma-
tion and edema. Representative T2 pseudocolored
coronal maps collected on days 1 and 7 after
inoculation are shown. E: The volume fraction of
inﬂammation (VF) caused by each strain was
calculated using thresholds 1 and 2, and disease
was modeled using nonlinear least squares.
F: Synovial ﬂuid [colony-forming unit (CFU)/mL]
was quantiﬁed. *P < 0.05 compared to wild-type
using repeated-measures analysis of variance;
***P < 0.001 versus wild-type using analysis of
variance.
Single Amino Acid Replacementaltered histopathological characteristics of the resulting ab-
scesses. Consistent with this hypothesis, microscopic exami-
nation of the skin lesions collected on day 7 after inoculation
(the time point when differences in lesion character were most
evident by visual examination) revealed that the isogenic Mga
H201R strain caused more tissue destruction and dissemina-
tion than the comparator strains (Figure 2C). The wild-type
strain had a virulence phenotype intermediate of the Mga-
deﬁcient and H201R strain (Figure 2, B and C).
The Mga H201R Amino Acid Replacement Signiﬁcantly
Increases GAS Virulence in a Monkey Model of Joint
Infection
GAS is a host-speciﬁc pathogen with exquisite speciﬁcity for
human molecules. Several proven and putative GAS virulenceThe American Journal of Pathology - ajp.amjpathol.orgfactors have modest to no activity against homologous
targets in mice.36,37 Therefore, mouse and other lower
vertebrate animal models, although widely used in
molecular pathogenesis research, may provide an incom-
plete understanding of the complex host-pathogen
interactions that underlie human-GAS disease. To this
end, the cynomolgus macaque has proved to be an
excellent phenocopy of GAS pharyngitis, pneumonia, and
necrotizing fasciitis in humans, and it has been success-
fully used in numerous GAS molecular pathogenesis
research studies.10,16,22,38e40 That is, the cynomolgus
macaque is the most human relevant model possible to
study GAS virulence.
Most invasive disease caused by M59 GAS manifests as
bacteremia, skin and soft tissue infection, and synovi-
tis.22,25 To further test the hypothesis that the Mga H201R467
Figure 4 Model of group A Streptococcus (GAS) Mga. A: Individual
domains of Mga are color coded: N-terminal DNA-binding domain with the
helix-turn-helix motifs in green, PRD-1 in yellow, PRD-2 in blue, and
C-terminal oligomerization domain in orange. The N- and C-terminal ends
are labeled. The side chains of H201, H207, and H273 are shown as
spheres. B: Magniﬁed view of amino acid H201 and its relative proximity to
the phosphorylatable H207 and H273 residues.
Sanson et alamino acid replacement increases GAS virulence, we
generated a new cynomolgus macaque model of joint
infection. For this experiment, each monkey served as its
own control, receiving the isogenic Mga wild-type strain in
one elbow and the H201R strain in the contralateral elbow.
Physical examination results revealed signs of joint
infection in all animals, including swollen and erythema-
tous joints bilaterally, altered posturing, and reluctance to
use the infected limbs. Noninvasive serial MR imaging
conﬁrmed that the isogenic Mga wild-type and H201R
strains both caused marked intra-articular and peri-articular
inﬂammation and edema at 1 and 2 days after inoculation
(Figure 3, A and B). However, the synovial disease rapidly
dissipated in elbows infected with the Mga wild-type strain
(Figure 3C). In comparison, the isogenic H201R strain
caused inﬂammation and edema that persisted for 7 days
(Figure 3D). Consistent with our hypothesis, the Mga
H201R strain caused signiﬁcantly more tissue damage,
inﬂammation, and edema overall (Figure 3E). Similarly,
signiﬁcantly more CFUs were recovered from synovial468ﬂuid collected from joints infected with the isogenic Mga
H201R strain compared to those receiving the wild-type
strain (Figure 3F).Discussion
Our laboratory has recently used whole-genome sequencing
to investigate the population genetic structure of GAS and
identify strain genotypeedisease phenotype relation-
ships.16,23,41 An emerging theme is that GAS organisms
can dramatically alter their virulence phenotype via SNPs
in major regulatory genes. That is, a single-nucleotide
change in a transcriptional regulator can exert wide-
ranging effects by altering the expression of multiple
virulence factors under its control. For example, naturally
occurring polymorphisms in the gene-encoding regulator
of protease B (ropB) alter 10% to 25% of the GAS
transcriptome.32,42,43 These ropB polymorphisms signiﬁ-
cantly decrease expression of the potent secreted protease
virulence factor SpeB that is crucial for tissue destruction
and systemic dissemination, and decrease GAS virulence
in mice and invasive infections in humans.32,42,43 Simi-
larly, Olsen et al10 demonstrated that a naturally occurring
SNP in the gene encoding the metal transporter of
Streptococcus regulator (mtsR) signiﬁcantly decreases the
ability of GAS to cause necrotizing fasciitis in nonhuman
primates and humans. In comparison, naturally occurring
amino acid replacements in the control of virulence
regulator/sensor (covR/S), an extensively studied two-
component transcriptional regulator in GAS, are well
known to increase strain virulence.44 Herein, we demon-
strated that the Mga H201R amino acid replacement also
signiﬁcantly increases GAS virulence. These ﬁndings
have important implications to vaccine design. Many
virulence factors regulated by regulator of protease B
(ropB), metal transporter of Streptococcus regulator
(mtsR), control of virulence regulator/sensor, and Mga
have been proposed for inclusion in vaccines.45e47 This
strategy needs to be carefully considered. If naturally
occurring mutations in transcription factors frequently
decrease the expression of some virulence factors in vivo,
then those molecules may not be ideal targets for inter-
vention. Rather, vaccines that include virulence factors
that are highly expressed in wild-type and mutant strains
may be more effective.
Our whole-genome sequencing studies demonstrated
mga to be the most highly polymorphic gene among
epidemic M59 GAS strains. In total, 48 different SNPs in
mga have been identiﬁed.22,23 Each is predicted to change
the encoded amino acid or result in premature termination,
suggesting selection for altered Mga sequences. Although
less common among the epidemic M59 GAS strains, SNPs
have also been identiﬁed in the covR, covS, ropB, and rofA
transcriptional regulators.23 Similar to the Mga H201R
amino acid substitution that arose independently at leastajp.amjpathol.org - The American Journal of Pathology
Single Amino Acid Replacementﬁve times, a single-nucleotide deletion that introduces a
premature stop codon in covS is also present in multiple
subclonal lineages.22 However, the biological effect of
these mutant alleles on strain virulence is unknown.
One possible explanation for the H201R amino acid
replacement leading to increased strain virulence is
disruption of the normal pathways that regulate tran-
scriptional activity by Mga. Results of the genome-wide
transcript studies (Figure 1) and animal infection models
(Figures 2 and 3) unambiguously demonstrated that
the Mga H201R amino acid replacement signiﬁcantly
increases expression of mga and Mga-regulated genes
and GAS virulence. To determine the possible molecular
mechanism underlying the increased virulence phenotype
of strains carrying the Mga H201R sequence, molecular
modeling simulations were performed using the
I-TASSER structure prediction server (http://zhanglab.
ccmb.med.umich.edu/I-TASSER, last accessed October
3, 2014).48 The model, using the M-protein transacting
positive regulator HTH domain protein from Entero-
coccus faecalis as a template, is predicted to have a
reliable template modeling score of 0.65 (Figure 4). Mga
consists of four domains, including an amino-terminal
DNA-binding domain with helix-turn-helix motifs, a
central domain with two phosphotransferase system
regulatory domains (PRD-1 and PRD-2), and a C-ter-
minal oligomerization domain.49 Hondorp et al49 recently
demonstrated that phosphorylation of two histidines in
the PRD-1 of Mga, H207 and H273, serve as a regulatory
switch for decreasing transcription activation. That is,
transcription activation by Mga is greatest when amino
acids H207 and H273 are not phosphorylated. The model
structure predicts that amino acid 201 lies on the same a
helix as the phosphorylatable H207 residue and in close
proximity to the phosphorylatable H273 residue
(Figure 4). Because the solubility of Mga with a histidine
or arginine at codon 201 is similar (data not shown), it is
unlikely that the amino acid replacement causes any
structural defect. Rather, the replacement of arginine,
which has a longer and positively charged side chain
compared to histidine, may prevent phosphorylation of
one or both PRD-1 histidines. Alternatively, the H201R
replacement may block phosphorylation-dependent
signal transduction from the PRD-1 domain to the
amino-terminal DNA-binding domain. As a result, M59
GAS strains with the Mga H201R sequence are signiﬁ-
cantly more virulent. Compared to wild-type M59 GAS
strains, Mga H201R strains have an increased ability to
adhere to host tissue, grow in situ, destroy tissue, and
cause inﬂammation and edema.
We generated a new nonhuman primate model of joint
infection to test hypotheses bearing on the virulence of a
human-speciﬁc pathogen. The use of nonhuman primates,
the most human-relevant animal model possible, com-
bined with MR imaging in a dedicated translational im-
aging suite was key to the success of this investigation.The American Journal of Pathology - ajp.amjpathol.orgAlthough imaging technologies have been extensively
used to study cancer and inﬂammatory disorders, they
have yet to become widely applied to infectious disease
research.50e52 MR imaging is the modality of choice for
imaging soft tissue infection, particularly synovitis,
because it can depict inﬂammation and edema.53 Still, the
current literature for MR imaging of invasive infections is
mostly limited to small animal models, selected case re-
ports, or case series with a few cases.54e56 Herein, we
used MR imaging to monitor disease progression and
compare the virulence of isogenic mutant strains, with
results directly bearing on the overarching hypothesis.
The ability to perform serial real-time imaging allowed
each animal to serve as its own control, thereby reducing
intrahost variation, increasing statistical power, and
decreasing costs. Performing the study on a clinical MR
human 3.0 T scanner housed in a dedicated translational
imaging facility also enables us to design custom MR
acquisition protocols that can be readily applied to
human imaging and facilitates the reﬁnement of our
model for future investigations. Serial noninvasive im-
aging data make practical the interpretation with a
mathematical model of disease progression over time in
a given host. Translating our mathematical approach to
research and diagnostic applications in patients is
thereafter straightforward.
In summary, we used whole-genome sequencing,22e24
genome-wide transcript analysis, and mouse and
nonhuman primate models of infection to demonstrate
that a naturally occurring single amino acid replacement
signiﬁcantly increases the virulence of M59 GAS. This
discovery provides a genetic basis, in part, for under-
standing differences in virulence phenotypes among
closely related strains. The investigative strategy should
be used with other medically important microbial path-
ogens, such as Staphylococcus aureus and Klebsiella
pneumoniae. Taken together, these data will improve our
understanding of strain genotypeedisease phenotype re-
lationships and can be used to generate new clinical
tools, such as diagnostics and vaccines.Acknowledgments
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